{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} In-Home Management of Diabetes and Obesity

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the results of recent new recommendations for weight loss.
  2. Choose the therapeutic effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors.
  3. Select the adverse effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors.
  4. Recognize the combination drugs available for patients who have type 2 diabetes mellitus and obesity.

Learning Outcomes

A majority of the participants of this activity will demonstrate knowledge of the indications, adverse effects, and potential safety considerations related to the use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors to ensure positive outcomes for patients with type 2 diabetes mellitus and obesity by achieving a passing score on the posttest.

Disclosures

All Authors and planners have disclosed no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: HHCN0124
Published: Jan/Feb 2024
Expires: 3/7/2025
Sources: Home Healthcare Now
Required Passing Score: 8/10 (80%)
Authors: Sonya Kowalski, DNP, APRN, ACNS-BC; Sara Gifford, DNP, RN, AGCNS-BC
Categories: Diabetes & Endocrine , Home Health Care
Specialties: Diabetes, Home Health
Topics: Diabetes , Obesity , Older Adults